Abstract
Summary
The global Muscle Relaxers market size is projected to grow from US$ 3815.2 million in 2022 to US$ 5664.7 million in 2029; it is expected to grow at a CAGR of 5.8% from 2023 to 2029.
United States market for Muscle Relaxers is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Muscle Relaxers is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Muscle Relaxers is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Muscle Relaxers players cover Novartis, Viatris, Teva Pharmaceuticals, Endo Pharmaceuticals, Mayne Pharma, Merck & Co. Inc, GSK, Casper Pharma LLC and Bayer, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
Muscle relaxers (also called muscle relaxants) are prescription medications that affect muscle function. Healthcare providers prescribe them to treat several symptoms, such as muscle spasms, spasticity and musculoskeletal pain.The term “muscle relaxant” refers to two major drug classes: antispastics and antispasmodics. These two classes differ in their uses, ways of working and side effects.
LPI (LP Information)' newest research report, the “Muscle Relaxers Industry Forecast” looks at past sales and reviews total world Muscle Relaxers sales in 2022, providing a comprehensive analysis by region and market sector of projected Muscle Relaxers sales for 2023 through 2029. With Muscle Relaxers sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Muscle Relaxers industry.
This Insight Report provides a comprehensive analysis of the global Muscle Relaxers landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Muscle Relaxers portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Muscle Relaxers market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Muscle Relaxers and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Muscle Relaxers.
This report presents a comprehensive overview, market shares, and growth opportunities of Muscle Relaxers market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Tablet
Capsule
Segmentation by application
Hospital
Clinic
Pharmacy
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Novartis
Viatris
Teva Pharmaceuticals
Endo Pharmaceuticals
Mayne Pharma
Merck & Co. Inc
GSK
Casper Pharma LLC
Bayer
BASF
ADVIL
Pfizer
Johnson & Johnson
Rosemont Pharmaceuticals
Key Questions Addressed in this Report
What is the 10-year outlook for the global Muscle Relaxers market?
What factors are driving Muscle Relaxers market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Muscle Relaxers market opportunities vary by end market size?
How does Muscle Relaxers break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
United States market for Muscle Relaxers is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Muscle Relaxers is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Muscle Relaxers is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Muscle Relaxers players cover Novartis, Viatris, Teva Pharmaceuticals, Endo Pharmaceuticals, Mayne Pharma, Merck & Co. Inc, GSK, Casper Pharma LLC and Bayer, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
Muscle relaxers (also called muscle relaxants) are prescription medications that affect muscle function. Healthcare providers prescribe them to treat several symptoms, such as muscle spasms, spasticity and musculoskeletal pain.The term “muscle relaxant” refers to two major drug classes: antispastics and antispasmodics. These two classes differ in their uses, ways of working and side effects.
LPI (LP Information)' newest research report, the “Muscle Relaxers Industry Forecast” looks at past sales and reviews total world Muscle Relaxers sales in 2022, providing a comprehensive analysis by region and market sector of projected Muscle Relaxers sales for 2023 through 2029. With Muscle Relaxers sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Muscle Relaxers industry.
This Insight Report provides a comprehensive analysis of the global Muscle Relaxers landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Muscle Relaxers portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Muscle Relaxers market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Muscle Relaxers and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Muscle Relaxers.
This report presents a comprehensive overview, market shares, and growth opportunities of Muscle Relaxers market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Tablet
Capsule
Segmentation by application
Hospital
Clinic
Pharmacy
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Novartis
Viatris
Teva Pharmaceuticals
Endo Pharmaceuticals
Mayne Pharma
Merck & Co. Inc
GSK
Casper Pharma LLC
Bayer
BASF
ADVIL
Pfizer
Johnson & Johnson
Rosemont Pharmaceuticals
Key Questions Addressed in this Report
What is the 10-year outlook for the global Muscle Relaxers market?
What factors are driving Muscle Relaxers market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Muscle Relaxers market opportunities vary by end market size?
How does Muscle Relaxers break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Muscle Relaxers Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Muscle Relaxers by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Muscle Relaxers by Country/Region, 2018, 2022 & 2029
2.2 Muscle Relaxers Segment by Type
2.2.1 Tablet
2.2.2 Capsule
2.3 Muscle Relaxers Sales by Type
2.3.1 Global Muscle Relaxers Sales Market Share by Type (2018-2023)
2.3.2 Global Muscle Relaxers Revenue and Market Share by Type (2018-2023)
2.3.3 Global Muscle Relaxers Sale Price by Type (2018-2023)
2.4 Muscle Relaxers Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Pharmacy
2.5 Muscle Relaxers Sales by Application
2.5.1 Global Muscle Relaxers Sale Market Share by Application (2018-2023)
2.5.2 Global Muscle Relaxers Revenue and Market Share by Application (2018-2023)
2.5.3 Global Muscle Relaxers Sale Price by Application (2018-2023)
3 Global Muscle Relaxers by Company
3.1 Global Muscle Relaxers Breakdown Data by Company
3.1.1 Global Muscle Relaxers Annual Sales by Company (2018-2023)
3.1.2 Global Muscle Relaxers Sales Market Share by Company (2018-2023)
3.2 Global Muscle Relaxers Annual Revenue by Company (2018-2023)
3.2.1 Global Muscle Relaxers Revenue by Company (2018-2023)
3.2.2 Global Muscle Relaxers Revenue Market Share by Company (2018-2023)
3.3 Global Muscle Relaxers Sale Price by Company
3.4 Key Manufacturers Muscle Relaxers Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Muscle Relaxers Product Location Distribution
3.4.2 Players Muscle Relaxers Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Muscle Relaxers by Geographic Region
4.1 World Historic Muscle Relaxers Market Size by Geographic Region (2018-2023)
4.1.1 Global Muscle Relaxers Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Muscle Relaxers Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Muscle Relaxers Market Size by Country/Region (2018-2023)
4.2.1 Global Muscle Relaxers Annual Sales by Country/Region (2018-2023)
4.2.2 Global Muscle Relaxers Annual Revenue by Country/Region (2018-2023)
4.3 Americas Muscle Relaxers Sales Growth
4.4 APAC Muscle Relaxers Sales Growth
4.5 Europe Muscle Relaxers Sales Growth
4.6 Middle East & Africa Muscle Relaxers Sales Growth
5 Americas
5.1 Americas Muscle Relaxers Sales by Country
5.1.1 Americas Muscle Relaxers Sales by Country (2018-2023)
5.1.2 Americas Muscle Relaxers Revenue by Country (2018-2023)
5.2 Americas Muscle Relaxers Sales by Type
5.3 Americas Muscle Relaxers Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Muscle Relaxers Sales by Region
6.1.1 APAC Muscle Relaxers Sales by Region (2018-2023)
6.1.2 APAC Muscle Relaxers Revenue by Region (2018-2023)
6.2 APAC Muscle Relaxers Sales by Type
6.3 APAC Muscle Relaxers Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Muscle Relaxers by Country
7.1.1 Europe Muscle Relaxers Sales by Country (2018-2023)
7.1.2 Europe Muscle Relaxers Revenue by Country (2018-2023)
7.2 Europe Muscle Relaxers Sales by Type
7.3 Europe Muscle Relaxers Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Muscle Relaxers by Country
8.1.1 Middle East & Africa Muscle Relaxers Sales by Country (2018-2023)
8.1.2 Middle East & Africa Muscle Relaxers Revenue by Country (2018-2023)
8.2 Middle East & Africa Muscle Relaxers Sales by Type
8.3 Middle East & Africa Muscle Relaxers Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Muscle Relaxers
10.3 Manufacturing Process Analysis of Muscle Relaxers
10.4 Industry Chain Structure of Muscle Relaxers
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Muscle Relaxers Distributors
11.3 Muscle Relaxers Customer
12 World Forecast Review for Muscle Relaxers by Geographic Region
12.1 Global Muscle Relaxers Market Size Forecast by Region
12.1.1 Global Muscle Relaxers Forecast by Region (2024-2029)
12.1.2 Global Muscle Relaxers Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Muscle Relaxers Forecast by Type
12.7 Global Muscle Relaxers Forecast by Application
13 Key Players Analysis
13.1 Novartis
13.1.1 Novartis Company Information
13.1.2 Novartis Muscle Relaxers Product Portfolios and Specifications
13.1.3 Novartis Muscle Relaxers Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Novartis Main Business Overview
13.1.5 Novartis Latest Developments
13.2 Viatris
13.2.1 Viatris Company Information
13.2.2 Viatris Muscle Relaxers Product Portfolios and Specifications
13.2.3 Viatris Muscle Relaxers Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Viatris Main Business Overview
13.2.5 Viatris Latest Developments
13.3 Teva Pharmaceuticals
13.3.1 Teva Pharmaceuticals Company Information
13.3.2 Teva Pharmaceuticals Muscle Relaxers Product Portfolios and Specifications
13.3.3 Teva Pharmaceuticals Muscle Relaxers Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Teva Pharmaceuticals Main Business Overview
13.3.5 Teva Pharmaceuticals Latest Developments
13.4 Endo Pharmaceuticals
13.4.1 Endo Pharmaceuticals Company Information
13.4.2 Endo Pharmaceuticals Muscle Relaxers Product Portfolios and Specifications
13.4.3 Endo Pharmaceuticals Muscle Relaxers Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Endo Pharmaceuticals Main Business Overview
13.4.5 Endo Pharmaceuticals Latest Developments
13.5 Mayne Pharma
13.5.1 Mayne Pharma Company Information
13.5.2 Mayne Pharma Muscle Relaxers Product Portfolios and Specifications
13.5.3 Mayne Pharma Muscle Relaxers Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Mayne Pharma Main Business Overview
13.5.5 Mayne Pharma Latest Developments
13.6 Merck & Co. Inc
13.6.1 Merck & Co. Inc Company Information
13.6.2 Merck & Co. Inc Muscle Relaxers Product Portfolios and Specifications
13.6.3 Merck & Co. Inc Muscle Relaxers Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Merck & Co. Inc Main Business Overview
13.6.5 Merck & Co. Inc Latest Developments
13.7 GSK
13.7.1 GSK Company Information
13.7.2 GSK Muscle Relaxers Product Portfolios and Specifications
13.7.3 GSK Muscle Relaxers Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 GSK Main Business Overview
13.7.5 GSK Latest Developments
13.8 Casper Pharma LLC
13.8.1 Casper Pharma LLC Company Information
13.8.2 Casper Pharma LLC Muscle Relaxers Product Portfolios and Specifications
13.8.3 Casper Pharma LLC Muscle Relaxers Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Casper Pharma LLC Main Business Overview
13.8.5 Casper Pharma LLC Latest Developments
13.9 Bayer
13.9.1 Bayer Company Information
13.9.2 Bayer Muscle Relaxers Product Portfolios and Specifications
13.9.3 Bayer Muscle Relaxers Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Bayer Main Business Overview
13.9.5 Bayer Latest Developments
13.10 BASF
13.10.1 BASF Company Information
13.10.2 BASF Muscle Relaxers Product Portfolios and Specifications
13.10.3 BASF Muscle Relaxers Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 BASF Main Business Overview
13.10.5 BASF Latest Developments
13.11 ADVIL
13.11.1 ADVIL Company Information
13.11.2 ADVIL Muscle Relaxers Product Portfolios and Specifications
13.11.3 ADVIL Muscle Relaxers Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 ADVIL Main Business Overview
13.11.5 ADVIL Latest Developments
13.12 Pfizer
13.12.1 Pfizer Company Information
13.12.2 Pfizer Muscle Relaxers Product Portfolios and Specifications
13.12.3 Pfizer Muscle Relaxers Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Pfizer Main Business Overview
13.12.5 Pfizer Latest Developments
13.13 Johnson & Johnson
13.13.1 Johnson & Johnson Company Information
13.13.2 Johnson & Johnson Muscle Relaxers Product Portfolios and Specifications
13.13.3 Johnson & Johnson Muscle Relaxers Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Johnson & Johnson Main Business Overview
13.13.5 Johnson & Johnson Latest Developments
13.14 Rosemont Pharmaceuticals
13.14.1 Rosemont Pharmaceuticals Company Information
13.14.2 Rosemont Pharmaceuticals Muscle Relaxers Product Portfolios and Specifications
13.14.3 Rosemont Pharmaceuticals Muscle Relaxers Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Rosemont Pharmaceuticals Main Business Overview
13.14.5 Rosemont Pharmaceuticals Latest Developments
14 Research Findings and Conclusion